Tuesday, June 28, 2016

“It was horrible,” she said. “I had flashbacks, returning nightmares, every symptom coming on full force, not to mention the withdrawal. After going off and back on four or five times, I told them, ‘I can’t do this anymore.’”

Falsified records, lax oversight, and an experimental PTSD drug from Pfizer, apparently with effects similar to those of January's ill-fated Bial study in France. That was enough for NYU to send psychiatric researcher Alexander Neumeister to the exit door.  And only four months after the FDA sent Neumeister a warning letter.

That's fast work, as these things go. Definitely a lot faster than eleven years. 

No comments:

Post a Comment